Archiv der Pharmazie

Papers
(The TQCC of Archiv der Pharmazie is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2216
Review on the pharmacological effects and pharmacokinetics of scutellarein204
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)73
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform66
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers57
Cover Picture: Arch Pharm (1/2024)50
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors45
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids45
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians43
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities42
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance41
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds40
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents40
A novel class for carbonic anhydrases inhibitors and evaluation of their non‐zinc binding39
Thiazole‐based SARS‐CoV‐2 protease (COV Mpro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations38
Piperlongumine and its derivatives against cancer: A recent update and future prospective37
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity34
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity32
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease32
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells29
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review28
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers27
26
Cover Picture: Arch Pharm (9/2021)26
Editorial Board: Arch Pharm (10/2023)26
Cover Picture: Arch Pharm (2/2024)26
24
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity24
New chimeric HDAC inhibitors for the treatment of colorectal cancer23
Combining chemical profiles and biological abilities of different extracts from Tanacetum nitens (Boiss. & NoëGrierson using network pharmacology22
Novel pyrazolo[3,4‐b]pyridine derivatives: Synthesis, structure–activity relationship studies, and regulation of the AMPK/70S6K pathway21
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies21
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids21
Evaluation of the effect of carvedilol orodispersible tablets on ischemia–reperfusion injury and flap viability in rats: An in vivo study21
Cover Picture: Arch Pharm (7/2023)21
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond20
Peripheral (E)‐2‐[(4‐hydroxybenzylidene)‐3,4‐dihydronaphthalen‐1(2H)‐one)]‐coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors20
The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach20
Structural determinants of sphingosine‐1‐phosphate receptor selectivity20
Aromatic linker variations in novel dopamine D2 and D3 receptor ligands20
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents20
Design, synthesis and biological evaluation of (E)‐kojyl‐styryl‐sulfones: Novel recilisib hybrids as promising radioprotectors20
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease19
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic KV7 channel openers: Exploration of a nicotinamide scaffold19
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation19
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells19
Uncovering chemical profiles, biological potentials, and protection effect against ECM destruction in H2O2‐treated HDF cells of the extracts of Stachys tundjeliensis19
Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells19
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors19
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory18
Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase VA and Pancreatic Lipase Inhibitor Through In Silico and In Vitro Studies17
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review16
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents16
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives16
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis16
Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β‐amyloid aggregation16
Cover Picture: Arch Pharm (6/2022)16
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors16
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review16
Safe and selective anticancer agents from tetrafluorinated azobenzene‐imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects15
Piperazine‐based P2X4 receptor antagonists15
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors15
N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer15
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential15
5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates15
14
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation14
Cytotoxic derivatives of dichloroacetic acid and some metal complexes14
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents14
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl2: Anticancer, docking, and DFT studies14
Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines14
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action14
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase13
13
Design, synthesis, and molecular docking of novel 3,5‐disubstituted‐1,3,4‐oxadiazole derivatives as iNOS inhibitors13
Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease13
13
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study13
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application13
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity13
13
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs13
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties12
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management12
Cover Picture: Arch Pharm (6/2023)12
Synthesis and evaluation of novel almazole D analogs as anticancer agents12
Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles12
Leishmanicidal and cytotoxic activities and 4D‐QSAR of 2‐arylidene indan‐1,3‐diones12
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development12
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis12
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively12
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors12
Purification of a novel protein with cytotoxicity against non‐small‐cell lung cancer cells from Boletus bicolor12
Biology‐oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors11
Up‐to‐date studies regarding the determination of melatonin by chromatographic methods11
Synthesis, Antituberculosis Evaluation and Structure–Activity Relationships of New SQ109 Analogs11
Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency11
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives11
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens11
Advances in polysaccharide‐based materials for biomedical and pharmaceutical applications: A comprehensive review11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes11
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction11
A new series of hydrazones as small‐molecule aldose reductase inhibitors11
Inhibitory effects of 190 compounds against SARS‐CoV‐2 Mpro protein: Molecular docking interactions10
Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies10
Issue Information: Arch Pharm (4/2025)10
10
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies10
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors10
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3)10
5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives10
Editorial Board: Arch Pharm (9/2021)10
10
A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth10
New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors10
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies10
Editorial Board: Arch Pharm (9/2023)10
Issue Information: Arch Pharm (4/2024)10
10
Greenness‐by‐design approach for developing novel UV spectrophotometric methodologies resolving a quaternary overlapping mixture9
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents9
Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives9
Health benefits of fraxetin: From chemistry to medicine9
Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration9
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors9
A virtual library of small molecules mimicking dipeptides9
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases9
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives9
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors9
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA9
Ginkgo biloba in the management of the COVID‐19 severity9
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020–2024)9
Research progress on the pathogenesis of psoriasis and its small molecule inhibitors8
The anti‐breast cancer potential of indole/isatin hybrids8
Metabolic profiling of Verbena bonariensis L. extract by LC/MS and evaluation of the hepatoprotective potential with isoniazid‐ and rifampicin‐induced hepatotoxicity in rats8
Eco‐friendly approaches to 1,3,4‐oxadiazole derivatives: A comprehensive review of green synthetic strategies8
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors8
Тhio‐containing pteridines: Synthesis, modification, and biological activity8
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists8
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking8
Issue Information: Arch Pharm (1/2025)8
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship8
New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes8
Issue Information: Arch Pharm (12/2024)8
Various pharmacological agents in the pipeline against intractable epilepsy8
Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies8
Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability8
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions8
Cover Picture: Arch Pharm (1/2022)8
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells8
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal struct8
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies8
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents8
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells8
New azaaurone derivatives as potential multitarget agents in HIV‐TB coinfection7
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis7
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors7
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents7
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway7
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors7
4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator7
7
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents7
Cover Picture: Arch Pharm (8/2023)7
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae7
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system7
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments7
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio7
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases7
A review of recent advances in anticancer activity and SAR of pyrazole derivatives7
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐197
Cover Picture: Arch Pharm (3/2022)7
1,2,3‐Triazole hybrids as anticancer agents: A review7
Emerging green synthetic routes for thiazole and its derivatives: Current perspectives7
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors7
Editorial Board: Arch Pharm (6/2022)7
Editorial Board: Arch Pharm (9/2022)7
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects7
Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation7
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate7
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review7
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities7
Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities7
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway7
Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review7
Cover Picture: Arch Pharm (10/2023)7
7
Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation7
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells6
Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats6
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties6
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments6
Cover Picture: Arch Pharm (9/2023)6
Novel N‐pyrocatechoyl and N‐pyrogalloyl hydrazone antioxidants endowed with cytotoxic and antibacterial activity6
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease6
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review6
Anti‐inflammatory activity of pyridazinones: A review6
TERRA G‐quadruplex stabilization behind the anti‐multiple myeloma activity: Novel insights about resveratrol pleiotropic effects6
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor6
The effects of morin and methotrexate on pentose phosphate pathway enzymes and GR/GST/TrxR enzyme activities: An in vivo and in silico study6
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors6
Simultaneous analysis of oxytetracycline hydrochloride, lidocaine, and bromhexine hydrochloride in the presence of many interfering excipients6
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules6
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors6
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris6
Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cells6
2,2,2‐Trifluoroethanol‐mediated hydroarylation of fluorinated alkynes with indoles: Application to diindolylmethanes6
SiteMine: Large‐scale binding site similarity searching in protein structure databases6
Radiosynthesis and whole‐body distribution in mice of a 18F‐labeled azepino[4,3‐b]indole‐1‐one derivative with multimodal activity for the treatment of Alzheimer's disease6
1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B6
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks6
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation6
Chicoric acid alleviates rotenone‐induced motor dysfunction in mice: Targeting PI3K/AKT/caspase‐3‐associated apoptosis and neuroinflammation6
Editorial Board: Arch Pharm (11/2021)6
6
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release6
Facile one‐pot synthesis of N‐pyridinylaminonaphthol derivatives and their antibacterial evaluation against multidrug‐resistant Staphylococcus aureus6
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents6
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation6
0.06626296043396